Efficacy and safety of eptinezumab in adults with chronic migraine and medication-overuse headache who also received patient education: 24-week results of the randomized RESOLUTION trial

Henrik W. Schytz, Rigmor H. Jensen, Christofer Lundqvist, Cristina Tassorelli, Fabrizio Vernieri, Michel Lantéri-Minet, Gisela M. Terwindt, Andrew Blumenfeld, Stewart J. Tepper, Mette Krog Josiassen, Gary Jansson, Anders Ettrup, Aurélia Mittoux, Richard B. Lipton

Open source

DOI: 10.1186/s10194-026-02423-x
Published: 2026-06-13
Container: The Journal of Headache and Pain
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s10194-026-02423-x,
  title = {Efficacy and safety of eptinezumab in adults with chronic migraine and medication-overuse headache who also received patient education: 24-week results of the randomized RESOLUTION trial},
  author = {Henrik W. Schytz and Rigmor H. Jensen and Christofer Lundqvist and Cristina Tassorelli and Fabrizio Vernieri and Michel Lantéri-Minet and Gisela M. Terwindt and Andrew Blumenfeld and Stewart J. Tepper and Mette Krog Josiassen and Gary Jansson and Anders Ettrup and Aurélia Mittoux and Richard B. Lipton},
  year = {2026},
  journal = {The Journal of Headache and Pain},
  doi = {10.1186/s10194-026-02423-x},
  url = {https://doi.org/10.1186/s10194-026-02423-x}
}

RIS

TY  - JOUR
TI  - Efficacy and safety of eptinezumab in adults with chronic migraine and medication-overuse headache who also received patient education: 24-week results of the randomized RESOLUTION trial
AU  - Henrik W. Schytz
AU  - Rigmor H. Jensen
AU  - Christofer Lundqvist
AU  - Cristina Tassorelli
AU  - Fabrizio Vernieri
AU  - Michel Lantéri-Minet
AU  - Gisela M. Terwindt
AU  - Andrew Blumenfeld
AU  - Stewart J. Tepper
AU  - Mette Krog Josiassen
AU  - Gary Jansson
AU  - Anders Ettrup
AU  - Aurélia Mittoux
AU  - Richard B. Lipton
PY  - 2026
JO  - The Journal of Headache and Pain
DO  - 10.1186/s10194-026-02423-x
UR  - https://doi.org/10.1186/s10194-026-02423-x
ER  -

APA

Schytz, H. W., Jensen, R. H., Lundqvist, C., Tassorelli, C., Vernieri, F., Lantéri-Minet, M., Terwindt, G. M., Blumenfeld, A., Tepper, S. J., Josiassen, M. K., Jansson, G., Ettrup, A., Mittoux, A., & Lipton, R. B. (2026). Efficacy and safety of eptinezumab in adults with chronic migraine and medication-overuse headache who also received patient education: 24-week results of the randomized RESOLUTION trial. The Journal of Headache and Pain. https://doi.org/10.1186/s10194-026-02423-x

Source records

crossref · retrieved 2026-11-11T01:47:42.400Z